CN Patent

CN108653231A — 含有布鲁顿酪氨酸激酶抑制剂的组合物及其制备方法

Assigned to Capital Pharmaceutical Holdings (Beijing) Co., Ltd. · Expires 2018-10-16 · 8y expired

What this patent protects

本发明为含有布鲁顿酪氨酸激酶抑制剂的组合物及其制备方法，涉及一种含有式(I)化合物或其药学上可接受的盐的药用组合物及其制备方法。本发明制得的组合物溶出度好，质量稳定，并能同时满足临床用药，患者顺应性等各项要求。

USPTO Abstract

本发明为含有布鲁顿酪氨酸激酶抑制剂的组合物及其制备方法，涉及一种含有式(I)化合物或其药学上可接受的盐的药用组合物及其制备方法。本发明制得的组合物溶出度好，质量稳定，并能同时满足临床用药，患者顺应性等各项要求。

Drugs covered by this patent

Patent Metadata

Patent number
CN108653231A
Jurisdiction
CN
Classification
—
Expires
2018-10-16
Drug substance claim
No
Drug product claim
No
Assignee
Capital Pharmaceutical Holdings (Beijing) Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.